Cullinan Therapeutics (CGEM) Earnings Date & Reports

A.I. Advisor

published Earnings

CGEM is expected to report earnings to rise 5.67% to -79 cents per share on November 11

Cullinan Therapeutics CGEM Stock Earnings Reports

Q3'24

Est.

$-0.79

Q2'24

Missed

by $0.02

Q1'24

Beat

by $0.13

Q4'23

Beat

by $0.42

Q3'23

Beat

by $0.01

The last earnings report on August 08 showed earnings per share of -75 cents, missing the estimate of -72 cents. With 394.07K shares outstanding, the current market capitalization sits at 996.62M.

View a ticker or compare two or three

Compare

CGEM

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For CGEM
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for CGEM (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

One Main Street

Phone

+1 617 410-4650

Employees

Web

https://www.cullinanoncology.com